NANJING SINOGEN BIOTECH & PHARMACEUTICAL INC has a total of 12 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and foods and drinks are ARTHROGEN B V, OXXON THERAPEUTICS LTD and ENGENEIC MOLECULAR DELIVERY PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 1 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Foods and drinks | |
#4 | Environmental technology | |
#5 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Enzymes | |
#5 | Climate change adaptation technologies | |
#6 | Peptides | |
#7 | Microorganisms | |
#8 | Specific use of cosmetics |
# | Name | Total Patents |
---|---|---|
#1 | Li Fanghong | 12 |
#2 | Lin Yan | 12 |
#3 | Zhou Sujin | 9 |
#4 | Zhao Zhenggang | 7 |
#5 | Zhao Allanzijian | 6 |
#6 | Xiang Rong | 3 |
#7 | Zhao Allan Zijian | 3 |
#8 | Li Xiaoxi | 2 |
#9 | Zhao Allan | 2 |
#10 | Yu Pengli | 2 |
Publication | Filing date | Title |
---|---|---|
EP3260531A1 | Transformant used for losing weight and reducing fat, construction method for transformant, and application of transformant | |
WO2016145974A1 | Use of gene engineering bacteria vpn 20009-m in preparation of medicaments for preventing and treating cancer metastasis | |
US9439934B1 | Application of an attenuated salmonella typhimurium, its genetically engineered bacterium in preparing drugs for the treatment of prostate cancer |